J. Bruce McClain

3.2k citations

29 papers · 1.8k indexed · 1 hit paper · h-index 17

Impact in

Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology
- Viral Infections and Vectors
Parasitology top 2%
- Leptospirosis research and findings

Papers in

Virology 4
- Rabies epidemiology and control 4
Infectious Diseases 15
- Tuberculosis Research and Epidemiology 9

Co-authors: Bernard Landry Willem A. Hanekom Michèle Tameris Mark Hatherill Hassan Mahomed Thomas J. Scriba Helen McShane Stephen Lockhart
Journals: Vaccine (10 papers)The Lancet (2 papers)Blood (2 papers)Annals of Internal Medicine (1 paper)Tuberculosis (1 paper)
Partner nations: United States South Africa Netherlands

In The Last Decade

J. Bruce McClain

27 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial 2013 · 753 citations

Peers

Countries citing papers authored by J. Bruce McClain

Since Specialization

Citations

This map shows the geographic impact of J. Bruce McClain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Bruce McClain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Bruce McClain more than expected).

Fields of papers citing papers by J. Bruce McClain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Bruce McClain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Bruce McClain. The network helps show where J. Bruce McClain may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Bruce McClain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Bruce McClain Line = papers co-authored together J. Bruce McClain links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The efficacy and safety of SYN023 (Zamerovimab and Mazorelvimab injection), the recombinant humanized anti-rabies virus monoclonal antibody mixture, combined with rabies vaccine in a WHO category III rabies post-exposure population: A randomized, double-blind, positive control, phase III clinical trial. Vaccine ·Xiaoqiang Liu, Jingyu Li, Yang Zha, Z. X. Wang, Ya Jiang, Xiangyu Zhang, Hyeon-Sul Lim, Jiajie Yu, Xiangjun Li, Qingchao Zhang, Caroline Reid, J. Bruce McClain, Eric Tsao	2025	0
2	A phase 2b, Randomized, double blinded comparison of the safety and efficacy of the monoclonal antibody mixture SYN023 and human rabies immune globulin in patients exposed to rabies Vaccine ·Beatriz P. Quiambao, Ronald Allan Payumo, Camilo C. Roa, Charissa Borja-Tabora, Liu Wenfeng, Linda Mills, 村野喜彦, María Rosario Capeding, Víctor Quintana Silveyra, J. Kowalska, Caroline Reid, Dave L. Braun, Eric Tsao, J. Bruce McClain	2024	4
3	Rabies virus neutralizing activity, pharmacokinetics, and safety of the monoclonal antibody mixture SYN023 in combination with rabies vaccination: Results of a phase 2, randomized, blinded, controlled trial Vaccine ·J. Bruce McClain, Dave L. Braun, Caroline Reid, Susan M. Moore, Eric Tsao	2021	14
4	Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials Vaccine ·Nerea Salmón, Timo Vesikari, Jilmar Castañeda-Ccori, Markus Maeurer, Raija Ahmed, Shahnaz Mahdavifar, Sean Bennett, J. Bruce McClain, Barbara Shepherd, Daner Li, David A. Hokey, Ingrid Kromann, Søren T. Hoff, Peter Andersen, Adriëtte W. de Visser, Simone A. Joosten, Tom H. M. Ottenhoff, Jan Andersson, Susanna Brighenti	2017	41
5	Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study The Lancet Respiratory Medicine ·Jason R. Andrews, Elisa Nemes, Michèle Tameris, Bernard Landry, Hassan Mahomed, J. Bruce McClain, Helen A. Fletcher, Willem A. Hanekom, Robin Wood, Helen McShane, Thomas J. Scriba, Mark Hatherill	2017	95
6	Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON®-TB Gold (+) Kenyan adults without evidence of tuberculosis Vaccine ·Douglas S. Walsh, Mark Rubin, Mark E. Polhemus, Lucas Otieno, Ben Andagalu, Bernhards Ogutu, John Waitumbi, Anthony Hawkridge, Barbara Shepherd, Maria Grazia Pau, Jerald Sadoff, Macaya Douoguih, J. Bruce McClain	2016	9
7	The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial Vaccine ·Hennie Geldenhuys, Helen Mearns, David J. C. Miles, Michèle Tameris, David A. Hokey, Zhongkai Shi, Sean Bennett, Peter Andersen, Ingrid Kromann, Søren T. Hoff, Willem A. Hanekom, Hassan Mahomed, Mark Hatherill, Thomas J. Scriba, Michele van Rooyen, J. Bruce McClain, Robert Ryall, Guy de Bruyn	2015	56
8	The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4+ T cell counts >350 cells/mm3 Vaccine ·Gavin Churchyard, Margaret Ann Snowden, David A. Hokey, Veerabadran Dheenadhayalan, J. Bruce McClain, Macaya Douoguih, Maria Grazia Pau, Jerry Sadoff, Bernard Landry	2015	24
9	Adenoviral-vectored tuberculosis vaccine AERAS-402 enhances T cell cytokine response in TB+ patients. (VAC12P.1026) The Journal of Immunology ·Andrew J. Graves, Richard N. van Zyl-Smit, Franciszek Tomczak, 公美子小田, Rodney Dawson, Jonathan Goldin, Eva M. van Rikxoort, Macaya Douoguih, Maria Grazia Pau, Jerald Sadoff, Sean Bennett, Margaret Ann Snowden, Jacqueline Gearhart, 神野幸雄, Lewis K. Schrager, J. Bruce McClain, Eric D. Bateman, David A. Hokey	2014	1
10	Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial The Lancet ·Michèle Tameris, Mark Hatherill, Bernard Landry, Thomas J. Scriba, Margaret Ann Snowden, Stephen Lockhart, Jacqueline E. Shea, J. Bruce McClain, Gregory Hussey, Willem A. Hanekom, Hassan Mahomed, Helen McShane Hit paper breakdown →	2013	753
11	Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG Tuberculosis ·Michèle Tameris, Helen McShane, J. Bruce McClain, Bernard Landry, Stephen Lockhart, Angelique Kany Kany Luabeya, Hennie Geldenhuys, Alison T. Varano, Gregory Hussey, Linda van der Merwe, Marwou de Kock, Thomas J. Scriba, Robert Walker, Willem A. Hanekom, Mark Hatherill, Hassan Mahomed	2013	30
12	A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity Vaccine ·Daniel F. Hoft, Azra Blazevic, Demi Fink, Bernard Landry, Donata Sizemore, Eloi Kpamegan, Jacqueline Gearhart, Alison Scott, Sandra V. Kik, Maria Grazia Pau, Jaap Goudsmit, J. Bruce McClain, Jerald Sadoff	2012	65
13	Safety Profile, Pharmacokinetics, and Pharmacodynamics of Siplizumab, A Humanized Anti-CD2 Monoclonal Antibody, in Renal Allograft Recipients Transplantation Proceedings ·T. Pruett, R. McGory, Francis H. Wright, Mark D. Pescovitz, Harry Yang, J. Bruce McClain	2009	14
14	Unusual persistence in healthy volunteers and ill patients of hyperimmune immunoglobulin directed against multiple Pseudomonas O-chain and Klebsiella serotypes after intravenous infusion Vaccine ·J. Bruce McClain, Robert Edelman, Nolder CraigA, John U. Que, Stanley J. Cryz, Alan S. Cross	2001	1
15	Experimental Gonococcal Urethritis and Reinfection with Homologous Gonococci in Male Volunteers Sexually Transmitted Diseases ·Katherine A. Schmidt, Herman Schneider, Ichijo Hodaka, John W. Boslego, 黄祖汉, Lillian Van De Verg, Carolyn Deal, J. Bruce McClain, J. McLeod Griffiss	2001	65
16	Laboratory evaluation of a dot-blot enzyme immunoassay for serologic confirmation of illness due to Rickettsia conorii. American Journal of Tropical Medicine and Hygiene ·ევტიხი ჟვანია, Daryl J. Kelly, Timothy Yong‐Kuei Lim, Bonnie L. Smoak, John F. Brundage, J. Bruce McClain, Whan-Seok Seo	1998	8
17	A Phase II Study of BTI-322, a Monoclonal Anti-CD2 Antibody, for Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease Blood ·Donna Przepiorka, Gordon L. Phillips, Voravit Ratanatharathorn, Michele Cottler‐Fox, Laurie H. Sehn, Joseph H. Antin, Donna LeBherz, Michel Awwad, James Hope, J. Bruce McClain	1998	47
18	Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously Vaccine ·Robert Edelman, Sandra Colins, Steven S. Wasserman, J. Bruce McClain, Alan S. Cross, Jerald Sadoff, John U. Que, Stanley J. Cryz	1994	58
19	Oral Ciprofloxacin and a Monoclonal Antibody to Lipopolysaccharide Protect Leukopenic Rats from Lethal Infection with Pseudomonas aeruginosa The Journal of Infectious Diseases ·H H Collins, Alan S. Cross, Arthur S. Dobek, Steven M. Opal, J. Bruce McClain, Jerald Sadoff	1989	35
20	Hemophilus parainfluenzae urethritis with accompanying bacteremia Clinical Microbiology Newsletter ·J. Bruce McClain, Hee-Deung Park, John Keiser	1983	0

About J. Bruce McClain

J. Bruce McClain is a scholar working on Virology, Infectious Diseases, Immunology, Parasitology and Hematology, having authored 29 papers that have together received 1.8k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (9 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Streptococcal Infections and Treatments (4 papers), Rabies epidemiology and control (4 papers), Pneumonia and Respiratory Infections (3 papers), Vector-borne infectious diseases (3 papers), Immune Cell Function and Interaction (3 papers) and vaccines and immunoinformatics approaches (3 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Parasitology (259 citations), Immunology (825 citations), Epidemiology (590 citations) and Virology (77 citations). J. Bruce McClain has collaborated with scholars based in United States, South Africa and Netherlands. Frequent co-authors include Bernard Landry, Willem A. Hanekom, Michèle Tameris, Mark Hatherill, Hassan Mahomed, Thomas J. Scriba, Helen McShane, Stephen Lockhart, Gregory Hussey and Margaret Ann Snowden. Their work appears in journals such as Vaccine, The Lancet, Blood, Annals of Internal Medicine and Tuberculosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact